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and Oene Wiegman 
Objective. To determine whether patients experi- 
encing high disease activity derive more benefit from 
patient education than those experiencing low disease 
activiq. 
Methods. Data from a randomized study on the ef- 
fects of a program of patient education were analyzed 
retrospectively Four subgroups were studied: the high 
disease activity subgroup of patients who had partic- 
ipated in the educational program, the complementary 
low disease activity subgroup, the high disease activity 
subgroup of controls, and its low disease activity com- 
plement. Patients with eq-throcyte sedimentation rate 
>28 mmlfirst hour were classified as having high dis- 
ease activity Effects on frequency of physical exercises, 
endurance exercises, and relaxation exercises and ef- 
fects on health status (Modified Health Assessment 
Questionnaire, Dutch Arthritis Impact Measurement 
Scales [AIMS]) were measured. 
Results. There were no significant differences be- 
tween the adherence parameters of the various pairs 
of groups. Four months after the educational program 
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began, anxiety and depression scores on the Dutch- 
AIMS had increased among participatingpatients who 
were experiencing high disease activity and decreased 
among those who were experiencing low disease ac- 
tivity. 
Conclusions. Patients experiencing high disease ac- 
tivity did not derive more benefit from patient edu- 
cation than those experiencing low disease activity On 
the contrav, an increase of anxiety and depression is 
found in these patients. Further study is needed to 
confirm our findings. 
Key words. Patient education; Rheumatoid arthritis: 
Disease activity. 
INTRODUCTION 
Persons with rheumatoid arthritis (RA) must face 
many physical, psychological, social, and economic 
problems (1-8). Beneficial effects of patient education 
on health behavior and on health status have been 
found in mixed populations of patients with different 
forms of rheumatic disease (9,101. Taal et a1 developed 
a self-management course for groups, based on the so- 
cial learning theory of Bandura (11,12) and a similarly 
based program of Lorig and colleagues (13,14). The 
results of this course were promising. Beneficial short- 
term effects included improved knowledge and self- 
efficacy expectations about physical functioning, in- 
creased adherence to physical exercise therapy and re- 
laxation exercise therapy, increased practice of self- 
management activities, and an improvement in func- 
tional ability. No improvements were found in the fre- 
quency with which endurance exercises were per- 
formed, nor in pain, depression, or anxiety. After 14 
months, there were still beneficial effects on knowl- 
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edge, adherence to physical exercise therapy, and self- 
efficacy expectations about physical functioning (15). 
Because RA patients with active disease are presum- 
ably confronted with more problems than those whose 
disease is in remission, we performed a retrospective 
investigation to determine whether level of disease ac- 
tivity was associated with the amount of benefit gained 
from the educational program. We considered out- 
comes with regard to adherence to treatment advice 
and health status. 
PATIENTS AND METHODS 
All outpatients between 21 and 65 years old, who had 
entered the practices of 3 rheumatologists less than 8 
years ago and fulfilled the American College of Rheu- 
matology (formerly the American Rheumatism Associa- 
tion) criteria for RA (16) were asked to participate. In- 
formed consent was obtained, and patients were then 
allocated at random to an experimental or a control 
group. These groups were subdivided according to the 
Westergren erythrocyte sedimentation rate (ESR) value 
into a high disease activity subgroup (ESR > 28 mm/ 
hour) and a low disease activity subgroup (ESR 5 28 
mm/hour). Other measures for disease activity deter- 
mined were: C-reactive protein (CRP; mg/liter), hemoglo- 
bin (mmol/liter), and a thrombocyte count (number x 
10g/liter). All patients continued their current treatments 
and were referred to physiotherapists for individual treat- 
ment and support. The experimental group attended 5 
meetings for patient education. The program included 
1) contracting, goal setting, and feedback 2) self-man- 
agement and problem-solving; 3) information on RA and 
its treatment, including medication, physical exercise 
therapy, endurance exercise therapy, relaxation exercise 
therapy, and pain management; 4) communication skills; 
5) coping with depression. 
Age, disease duration, functional class according to 
Steinbrocker et a1 (17), and adherence to physical, en- 
durance, and relaxation exercise therapies (number of 
times per week) were ascertained by questionnaire at 
the beginning of the study. Health status was measured 
with the Dutch Arthritis Impact Measurement Scales 
(AIMS) and the Modified Health Assessment Ques- 
tionnaire (M-HAQ). After 4 months, adherence, Dutch- 
AIMS, and M-HAQ were reassessed. 
Dutch-AIMS is a Dutch language version of the AIMS 
health status questionnaire (18-20). We used its 5 series 
of questions on physical health, the 2 series on psy- 
chological health, and the series on pain. The physical 
health series deal with mobility, physical activities, 
dexterity, household activities, and activities of daily 
living. The psychological health series deal with anx- 
iety and depression. The range of scores for each series 
is from 0 to 10, where 0 represents good health and 10 
poor health. Overall physical health and psychological 
health scores are obtained by adding the scores for their 
constituent dimensions. 
The M-HAQ (21) is a short questionnaire that mea- 
sures physical disability. Its scores range from l to 4, 
where 1 represents good function and 4 poor function, 
Statistics. The initial data of the experimental group 
had been compared with those of the control group by 
Tad et al(15). To validate ow classification of the patients 
into subgroups with high and low disease on the basis 
of ESR, we compared the CRP, the hemoglobin, and the 
thrombocyte count of the total high ESR group with those 
of the total low ESR group. In our study we compared 
the initial scores as well as the changes in the scores after 
4 months in 4 pairs of subgroups. The Wilcoxon two 
sample test was used. Spearman’s rank correlation co- 
efficient was computed between disease duration and the 
psychological health series of the Dutch-AIMS in the total 
population, as well as between the disease duration and 
the 4 months’ change in these series. The data of patients 
who withdrew from or dropped out of the study were 
not included in the analysis, 
RESULTS 
One hundred forty patients fulfilled the selection cri- 
teria. Seventy-five gave informed consent. Of these, 38 
were allocated to the experimental group and 37 to the 
control group. There were 6 withdrawals from the ex- 
perimental group and 7 from the control group. ESR 
was unavailable from 2 patients in the control group. 
There were no significant differences in age, disease 
duration, functional class, adherence, or health scores 
between the experimental and control groups at the 
beginning of the study (Table 1). 
In the total population there were 47 patients classified 
as having low disease activity, and 13 classified as having 
high disease activity. Mean values of CRP were 1 2  (SD 
7) and 37 (SD 23) mg/liter in the respective groups (P < 
0.001), of hemoglobin 8.5 (SD 0.7) and 7.9 (SD 0.9) mmol/ 
liter (P < 0.05), and of the thrombocyte count 265 (SD 
55) and 311 (SD 72) X 10Q/liter (P < 0.05). 
The high disease activity subgroup of the experi- 
mental group consisted of 7 patients, the low disease 
activity subgroup of 25. The high disease activity sub- 
group of the control group consisted of 6 patients, the 
low disease activity subgroup of 22. The only statis- 
tically significant difference between complementary 
subgroups at the beginning of the study was that dis- 
ease duration was shorter in the low disease activity 
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Table 1. Initial patient characteristics, mean (SD)* 
Vol. 10, No. 5, October 1997 
Experimental Control 
(n = 28) 
group group 
(n = 32) 
Age, years 50.5 (10.4) 49.3 (10.9) 
RA duration, years 3.8 (3.6) 4.9 (5.1) 
Steinbrocker (1-4)t 1.9 (0.5) 1.8 (0.5) 
Physical exercise (timedweek) 1.90 (2.81) 3.48 (6.60) 
Endurance exercise (timedweek) 7.00 (5.76) 8.43 (6.46) 
Relaxation exercise (timedweek) 2.62 (3.19) 2.79 (4.68) 
AIMS Physical (0-50)t 10.32 (6.91) 9.15 (5.29) 
AIMS Psychological (0-20)t 5.76 (3.58) 5.86 (2.88) 
M-HAQ (1-4)t 1.42 (0.46) 1.24 (0.36) 
* No statistically significant differences were found between the experimental and 
control groups. RA = rheumatoid arthritis; AIMS = Arthritis Impact Measurement 
Scales; M-HAQ = Modified Health Assessment Questionnaire. 
t A low score represents good health. 
AIMS Pain (0-10)t 4.78 (2.11) 4.59 (1.90) 
subgroup of the experimental group than in the high 
disease activity subgroup of that group (Table 2). 
The changes in the adherence scores of the 2 high 
disease activity subgroups after 4 weeks were not sig- 
nificantly different from those of their low disease ac- 
tivity complements. Neither were there significant dif- 
ferences between corresponding subgroups of the 
experimental and control groups in this regard (Table 2). 
The score on the psychological dimension of the 
Dutch-AIMS of the high disease activity subgroup of 
the experimental group increased, while that of the low 
disease activity subgroup of the experimental group 
decreased; the difference between the changes from 
baseline in these subgroups was statistically signifi- 
cant. The correlation between the disease duration and 
the psychological dimension of the Dutch-AIMS in the 
total population at baseline was -0.03 (not significant). 
The correlation between the disease duration and the 
change from baseline in the psychological dimension 
was -0.003 (not significant). There were no statistically 
significant differences between the high disease activ- 
ity subgroup of the control group and its low disease 
activity complement with regard to Dutch-AIMS and 
M-HAQ, and no statistically significant differences in 
this regard between the high disease activity subgroup 
in the experimental group and that in the control 
group. In the low disease activity subgroup of the ex- 
perimental group, the M-HAQ score had decreased af- 
ter 4 months; in the corresponding subgroup of the 
control group it had increased. This difference is sta- 
tistically significant (Table 2). 
DISCUSSION 
It is conceivable that the effects of group education 
are not the same for all patients, or that some patients 
need a different approach than others. We expected 
patient education to be more beneficial for patients 
with high disease activity with regard to adherence or 
health status, but the results of our study did not sup- 
port this expectation. 
There is no consensus about how to measure disease 
activity (22-25). We chose the ESR for that purpose 
because it is an inexpensive and easily performed mea- 
sure. The cut-off point of 28 mm/first hour is com- 
monly used to help discriminate active disease from 
less active disease. Other measures for disease activity 
(CW, hemoglobin, and thrombocyte count) were dif- 
ferent in the high and low disease activity groups, thus 
indicating the validity of our classification of patients 
into high and low disease activity groups on basis of 
the ESR cut-off point of 28 mm/first hour. 
Surprisingly, we found that patients with high dis- 
ease activity became more anxious and depressed fol- 
lowing patient education, while the other patients of 
the experimental group became less anxious and de- 
pressed. There is some concern about the reliability of 
this finding because of the small samples for the high 
disease activity experimental group (n = 7) and the 
high disease activity control group (n = 6). An addi- 
tional concern is the difference in disease duration be- 
tween the high and the low disease activity subgroup 
in the experimental group. However it is unlikely that 
this difference in disease duration has biased our re- 
sults with regard to anxiety and depression, because 
disease duration did not correlate with the scores on 
the psychological dimension of the Dutch-AIMS at 
baseline (r = 0.03), nor with the changes from baseline 
in the same variable (r = -0.003). 
The increase in anxiety and depression following 
patient education among patients with a high disease 
activity could be the result of increased awareness of 
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Table 2. Initial mean scores and changes after 4 months in the high and low disease activity subgroups 
of the experimental and control groups, mean (SD)" 
Experimental group Control group 
(n = 32) (n = 28) 
ESR > 28 ESR 5 28 ESR > 28 ESR 5 28 
(n = 7) (n = 25) (n = 6) (n = 22) 
Age, years 
RA duration, years 
Steinbrocker (I+)$ 
Physical exercise (timedweek) 
Baseline 
Change 0-4 months 
Endurance exercise [timedweek) 
Baseline 
Change 0 4  months 
Relaxation exercise (timedweek) 
Baseline 
Change 0-4 months 
AIMS Physical (0-50)$ 
Baseline 
Change 0 4  months 
Baseline 
Change 0-4 months 
AIMS Psychological (0-20)* 
AIMS Pain (0-10)$ 
Baseline 
Change 0-4 months 
M-HAQ (1-4)$ 
Baseline 
Change 0 4  months 
51.6 (9.3) 
5.4 (2.5)t 
2.14 (0.4) 
50.2 (10.8) 
3.4 (3.8)t 
1.8 (0.5) 
50.2 (11.2) 
8.5 (10.1) 
2.2 (0.4) 
49.0 (11.0) 
4.0 (2.3) 
1.7 (0.5) 
2.29 (2.36) 
1.29 (2.69) 
1.77 (3.00) 
1.90 (3.06) 
1.83 (2.56) 
1.50 (4.37) 
3.95 (7.35) 
-1.95 (7.24) 
6.83 (7.68) 
0.00 (1.27) 
7.06 (5.21) 
0.76 (3.85) 
10.00 (11.11) 
0.60 (3.8) 
7.94 (4.65) 
3.63 (6.40) 
2.71 (3.15) 
0.00 (1.53) 
2.59 (3.28) 
0.73 (2.66) 
1.67 (1.75) 
0.33 (1.97) 
3.09 (5.19) 
-0.53 (6.18) 
12.75 (5.96) 
1.94 (4.68) 
9.64 (7.11) 
-1.32 (4.90) 
12.23 (4.99) 
-1.55 (4.13) 
7.73 (4.97) 
-0.58 (2.10) 
5.05 (3.88) 
1.11 (1.50)s 
5.97 (3.55) 
-1.38 (2.34)s 
6.28 (3.83) 
-0.89 (1.64) 
5.75 (2.66) 
-1.00 (1.87) 
5.64 (1.07) 
-0.07 (1.20) 
4.54 (2.28) 
-0.30 (2.45) 
5.08 (2.08) 
-1.08 (2.75) 
4.45 (1.87) 
-0.64 (1.92) 
1.57 (0.45) 
0.07 (0.39) 
1.37 (0.46) 
-0.03 (0.31)t 
1.40 (0.39) 
0.26 (0.30) 
1.20 (0.35) 
0.04 (0.15)t 
* Comparisons between experimental group with ESR > 28 and experimental group with ESR 5 28, between control group with ESR 
> 28 and control group with ESR 5 28, between experimental group with ESR > 28 and control group with ESR > 28, between 
experimental group with ESR 5 28 and control group with ESR 5 28. ESR = erythrocyte sedimentation rate; RA = rheumatoid arthritis: 
AIMS = Arthritis Impact Measurement Scales; M-HAQ = Modified Health Assessment Questionnaire. 
t P < 0.05. 
f A low score represents good health. 
s P = 0.01. 
the consequences of the high disease activity for func- 
tional ability and its association with damage to the 
joints. The finding that these patients became more 
anxious and depressed does not appear to support the 
hypothesis that these are the patients that should ben- 
efit most. It is not clear, however, whether it should be 
taken as a positive or a negative effect. Is it a final 
outcome or will it be conducive to more effective 
modes of coping and hence to an improvement in 
health? 
Because treatment with disease-modifying antirheu- 
matic drugs is the only therapy that has been proven 
to reduce disease activity (26), improving adherence to 
this treatment should perhaps be included as an im- 
portant and specific aim of patient education when 
patients experiencing high disease activity are in- 
volved. 
The only other difference that we found, that M-HAQ 
scores improved more in the high disease activity sub- 
group of the experimental group than in the corre- 
sponding subgroup of the control group, is in line with 
the positive effects of patient education on disability 
found by Taal et a1 in their earlier study. Because of 
the small sample sizes, we may have missed other sig- 
nificant influences of disease activity on the effects of 
patient education on adherence or health status (Type 
2 errors). 
Many studies have shown that increases in adher- 
ence and improvement of health status can be achieved 
with patient education (9,lO). The results of our study 
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suggest that the subgroup of RA patients with high 
disease activity experienced n o  additional benefit from 
patient education when compared to those with low 
disease activity. Patient education might even evoke 
anxiety and depression in these patients. Because of 
small sample sizes for the high disease activity sub- 
groups in our study, no  final conclusions can be drawn 
yet the effects Of patient education 
among RA patients with high disease activity and low 
disease activity, and further study is needed. 
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